A nonsurgical treatment for prostate enlargement via pulsed
electromagnetic field therapy (PEMF) is underway and will be available soon.
This is cheerful news for old people who are vulnerable to
benign prostatic hyperplasia (BPH), which is a urological condition caused by a
benign increase in the size of the prostate as men get older. A recent study on dogs with BPH offers hope for a non-invasive option to treat an enlarged prostate.
Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia (BPH) or Benign Enlargement of Prostate (BEP) is an increase in the size of the prostate. The prostate is a walnut sized gland that is part of the male reproductive system.
Advertisement
Men suffering from BPH struggle with urinary tract problems, urethral obstruction, urine blood and sexual dysfunction.
Researchers carried out a non-invasive treatment trial on
dogs with BPH. The trial was a success
since it was able to reduce the size of the prostate gland, and the researchers
hope this would work for humans too.
![Prostate Cancer Screening]( "Prostate Cancer Screening")
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.
The new methodology used in the trial on dogs was pulsed electromagnetic field therapy (PEMF), which is a noninvasive treatment method that generates both an electrical and magnetic field and is currently in use in orthopedics, neurology, and urology.
The dogs involved in the study were treated with PEMF for 5 minutes, twice a day for three weeks. The device was just held over the skin of prostate location.
There was tremendous progress in reduction of the size of the prostate of about 57% in dogs. There was no compromise in semen quality, libido or the levels of testosterone.
Doppler studies showed a reduction of peripheral blood resistances and a progressive reduction in blood flow resistance in the prostatic artery dorsal branch.
Raffaella Leoci, lead author of the research, said, "Previous studies have suggested that reduced blood flow to the prostate gland and resulting inflammation contribute to the development of BPH. We know that PEMF has positive effects on similar conditions, so we thought it might also heal BPH or may be even prevent BPH from developing."
The study appeared in the journal The Prostate.
Source: Medindia
Prostate Cancer Screening
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.
Advertisement
The new methodology used in the trial on dogs was pulsed electromagnetic field therapy (PEMF), which is a noninvasive treatment method that generates both an electrical and magnetic field and is currently in use in orthopedics, neurology, and urology.
The dogs involved in the study were treated with PEMF for 5 minutes, twice a day for three weeks. The device was just held over the skin of prostate location.
There was tremendous progress in reduction of the size of the prostate of about 57% in dogs. There was no compromise in semen quality, libido or the levels of testosterone.
Doppler studies showed a reduction of peripheral blood resistances and a progressive reduction in blood flow resistance in the prostatic artery dorsal branch.
Raffaella Leoci, lead author of the research, said, "Previous studies have suggested that reduced blood flow to the prostate gland and resulting inflammation contribute to the development of BPH. We know that PEMF has positive effects on similar conditions, so we thought it might also heal BPH or may be even prevent BPH from developing."
The study appeared in the journal The Prostate.
Source: Medindia
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/300x250/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.
Advertisement
 Genetic Testing may be Used to Identify BPH Patients With Increased Risk of Prostate CancerA new study has revealed that patients with benign prostatic hyperplasia (BPH) carrying prostate cancer a (PCa) risk alleles are a potential target population. | Advertisement
|
Advertisement
Recommended Readings
Latest Menīs Health News
Men can have adverse effects on erectile dysfunction due to prolonged space travel and high amounts of galactic cosmic radiation.
Diagnostic lipid markers for metabolic syndrome and SCFAs correlate with interleukin immunoexpression in benign hyperplasia prostate tissue.
A combination of decitabine that targets loss of the gene RB1 and DS-7300a that targets the B7-H3 receptors effectively reduces advanced prostate tumor growth.
Research reveals a robust association between insecticide exposure and decreased sperm concentration in adult men globally.
Impact of fathers' mental well-being on child development remains a relatively uncharted territory and is explored by a recent study.